Iksuda Therapeutics (Iksuda), the developer of class leading, antibody drug conjugates (ADCs), today announces the presentation of new data from its Phase 1 study of IKS014, a human epidermal growth ...

"The scale at which China has managed to transition so far is testament to its unwavering commitment to the technologies of ...

Adverse events (AEs) generally transient and readily manageable; only 2 cases of cytokine release syndrome (CRS)Prolonged tumor control with ...

Resolution Minerals’ US critical minerals ambitions have been validated, with global fund manager Tribeca Investment Partners ...

Universities invest millions of pounds in providing a good student experience, but the evidence of this year's National ...

Metallurgical studies of composite Frost Cove antimony vein material continue at SGS Lakefield and have demonstrated ...

Microsoft, OpenAI and Anthropic are providing millions of dollars for AI training to the American Federation of Teachers, the ...

American Eagle Outfitters (AEO) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

For many young Americans, choosing where to go to college — or whether to go at all — revolves around a single question: Is ...

Discover Delcath’s innovative liver-targeted chemotherapy system and latest clinical data driving potential market expansion.

As we look to 2026 and beyond, the question isn’t whether we’ll solve the power challenge, according to Rehlko's Ryan DeLoge.